Autologous Tumor-infiltrating Lymphocyte（Binuoji）
自体肿瘤浸润淋巴细胞（毕诺济）
Report date: 2026/04/17 10:36:28
Base Information
Drug NameAutologous Tumor-infiltrating Lymphocyte（Binuoji）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBinuoji (Shanghai) Biotechnology Co Ltd +[2]
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A